Andrew T. Reardon
Chief Legal Officer & SecretaryMr. Andrew T. Reardon, J.D., serves as Chief Legal Officer of Ligand Pharmaceuticals Incorporated and serves as its Secretary. He was the Managing Director and Chief Legal Officer at Healthcare Royalty Partners since January 2020. Prior to this, Mr. Reardon was a Senior Associate at Willkie Farr & Gallagher. Mr. Reardon’s experience includes advising private equity funds, hedge funds, lenders and operating companies on matters including fund formations, financings, equity issuances, mergers and acquisitions, leveraged buyouts, royalty transactions, restructurings and corporate governance. Mr. Reardon is a former officer with the United States Army National Guard. Mr. Reardon received a J.D., with high distinction, from The University of Iowa College of Law where he was the recipient of the Alan I. Widiss Faculty Scholar Award and a B.A., with honors, from the State University of New York, College. He is Director of XOMA Royalty Corporation from July 14, 2026.
Positions
- Company NameLigand Pharmaceuticals IncorporatedStock CodeLGNDPositionChief Legal Officer & SecretaryColleagues
- TCTodd C. DavisCEO & Director
- JWJohn Warren KozarichIndependent Chairman
- OEOctavio EspinozaChief Financial Officer
- PJPaul J. HaddenSenior Vice President of Investments & Business Development
- MJMelanie J. HermanExecutive Director of Investor Relations and Financial Planning & Analysis
- JMJason M. AryehIndependent Director
- SLStephen Lawrence SabbaIndependent Director
- JHJason HaasIndependent Director
